These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1203 related articles for article (PubMed ID: 31278754)

  • 41. Amelioration of Hepatic Steatosis in Mice through
    Lee HB; Do MH; Jhun H; Ha SK; Song HS; Roh SW; Chung WH; Nam YD; Park HY
    Nutrients; 2021 Aug; 13(9):. PubMed ID: 34578867
    [TBL] [Abstract][Full Text] [Related]  

  • 42. High-fat, high-fructose diet induces hepatic iron overload via a hepcidin-independent mechanism prior to the onset of liver steatosis and insulin resistance in mice.
    Tsuchiya H; Ebata Y; Sakabe T; Hama S; Kogure K; Shiota G
    Metabolism; 2013 Jan; 62(1):62-9. PubMed ID: 22854109
    [TBL] [Abstract][Full Text] [Related]  

  • 43. PEGylated Curcumin Derivative Attenuates Hepatic Steatosis via CREB/PPAR-
    Liu Y; Cheng F; Luo Y; Zhan Z; Hu P; Ren H; Tang H; Peng M
    Biomed Res Int; 2017; 2017():8234507. PubMed ID: 28770225
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Niacin increases diet-induced hepatic steatosis in B6129 mice.
    Fang H; Li Z; Graff EC; McCafferty KJ; Judd RL
    Biochim Biophys Acta Mol Cell Biol Lipids; 2020 Sep; 1865(9):158731. PubMed ID: 32404278
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Mechanisms of hepatic triglyceride accumulation in non-alcoholic fatty liver disease.
    Kawano Y; Cohen DE
    J Gastroenterol; 2013 Apr; 48(4):434-41. PubMed ID: 23397118
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Susceptibility of Different Mouse Wild Type Strains to Develop Diet-Induced NAFLD/AFLD-Associated Liver Disease.
    Fengler VH; Macheiner T; Kessler SM; Czepukojc B; Gemperlein K; Müller R; Kiemer AK; Magnes C; Haybaeck J; Lackner C; Sargsyan K
    PLoS One; 2016; 11(5):e0155163. PubMed ID: 27167736
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Bavachin protects against diet-induced hepatic steatosis and obesity in mice.
    Wei X; Lin L; Yuan QQ; Wang XY; Zhang Q; Zhang XM; Tang KC; Guo MY; Dong TY; Han W; Huang DK; Qi YL; Zhang M; Zhang HB
    Acta Pharmacol Sin; 2023 Jul; 44(7):1416-1428. PubMed ID: 36721007
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Ipragliflozin Improves Hepatic Steatosis in Obese Mice and Liver Dysfunction in Type 2 Diabetic Patients Irrespective of Body Weight Reduction.
    Komiya C; Tsuchiya K; Shiba K; Miyachi Y; Furuke S; Shimazu N; Yamaguchi S; Kanno K; Ogawa Y
    PLoS One; 2016; 11(3):e0151511. PubMed ID: 26977813
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Dietary modification dampens liver inflammation and fibrosis in obesity-related fatty liver disease.
    Larter CZ; Yeh MM; Haigh WG; Van Rooyen DM; Brooling J; Heydet D; Nolan CJ; Teoh NC; Farrell GC
    Obesity (Silver Spring); 2013 Jun; 21(6):1189-99. PubMed ID: 23666886
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Biochanin A improves hepatic steatosis and insulin resistance by regulating the hepatic lipid and glucose metabolic pathways in diet-induced obese mice.
    Park HS; Hur HJ; Kim SH; Park SJ; Hong MJ; Sung MJ; Kwon DY; Kim MS
    Mol Nutr Food Res; 2016 Sep; 60(9):1944-55. PubMed ID: 27145114
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Rho-kinase/AMPK axis regulates hepatic lipogenesis during overnutrition.
    Huang H; Lee SH; Sousa-Lima I; Kim SS; Hwang WM; Dagon Y; Yang WM; Cho S; Kang MC; Seo JA; Shibata M; Cho H; Belew GD; Bhin J; Desai BN; Ryu MJ; Shong M; Li P; Meng H; Chung BH; Hwang D; Kim MS; Park KS; Macedo MP; White M; Jones J; Kim YB
    J Clin Invest; 2018 Dec; 128(12):5335-5350. PubMed ID: 30226474
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Non-Alcoholic Fatty Liver Disease.
    Engin A
    Adv Exp Med Biol; 2017; 960():443-467. PubMed ID: 28585211
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Brain leptin reduces liver lipids by increasing hepatic triglyceride secretion and lowering lipogenesis.
    Hackl MT; Fürnsinn C; Schuh CM; Krssak M; Carli F; Guerra S; Freudenthaler A; Baumgartner-Parzer S; Helbich TH; Luger A; Zeyda M; Gastaldelli A; Buettner C; Scherer T
    Nat Commun; 2019 Jun; 10(1):2717. PubMed ID: 31222048
    [TBL] [Abstract][Full Text] [Related]  

  • 54. GCN2 deficiency protects against high fat diet induced hepatic steatosis and insulin resistance in mice.
    Liu S; Yuan J; Yue W; Bi Y; Shen X; Gao J; Xu X; Lu Z
    Biochim Biophys Acta Mol Basis Dis; 2018 Oct; 1864(10):3257-3267. PubMed ID: 30006154
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Reducing endogenous insulin is linked with protection against hepatic steatosis in mice.
    Akheruzzaman M; Hegde V; Shin AC; Dhurandhar NV
    Nutr Diabetes; 2020 Apr; 10(1):11. PubMed ID: 32286259
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Fructose as a key player in the development of fatty liver disease.
    Basaranoglu M; Basaranoglu G; Sabuncu T; Sentürk H
    World J Gastroenterol; 2013 Feb; 19(8):1166-72. PubMed ID: 23482247
    [TBL] [Abstract][Full Text] [Related]  

  • 57. In Vivo Investigation of High-Fat Diet-Induced Hepatic Lipid Dysfunctions.
    Korach-André M
    Methods Mol Biol; 2020; 2164():109-119. PubMed ID: 32607888
    [TBL] [Abstract][Full Text] [Related]  

  • 58. CTRP3 attenuates diet-induced hepatic steatosis by regulating triglyceride metabolism.
    Peterson JM; Seldin MM; Wei Z; Aja S; Wong GW
    Am J Physiol Gastrointest Liver Physiol; 2013 Aug; 305(3):G214-24. PubMed ID: 23744740
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Hepatic mTOR-AKT2-Insig2 signaling pathway contributes to the improvement of hepatic steatosis after Roux-en-Y Gastric Bypass in mice.
    Pan Q; Qin T; Gao Y; Li S; Li D; Peng M; Zhai H; Xu G
    Biochim Biophys Acta Mol Basis Dis; 2019 Mar; 1865(3):525-534. PubMed ID: 30562559
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Reduced mitochondrial mass and function add to age-related susceptibility toward diet-induced fatty liver in C57BL/6J mice.
    Lohr K; Pachl F; Moghaddas Gholami A; Geillinger KE; Daniel H; Kuster B; Klingenspor M
    Physiol Rep; 2016 Oct; 4(19):. PubMed ID: 27694529
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 61.